Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02549651
Title MEDI4736 Alone and in Combination With Tremelimumab or AZD9150 in Adult Subjects With Diffuse Large B-cell Lymphoma (D4190C00023)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors MedImmune LLC
Indications

diffuse large B-cell lymphoma

Therapies

Durvalumab + Tremelimumab

Durvalumab

AZD9150 + Durvalumab

Age Groups: adult | senior
Covered Countries USA | FRA

Facility Status City State Zip Country Details
Research Site La Jolla California 92093 United States Details
Research Site Baltimore Maryland 21201 United States Details
Research Site Albuquerque New Mexico 87131 United States Details
Research Site Durham North Carolina 27710 United States Details
Research Site Charleston South Carolina 29425 United States Details
Research Site Dallas Texas 75390 United States Details
Research Site Houston Texas 77030 United States Details
Research Site Milwaukee Wisconsin 53226 United States Details
Research Site Marseille 13273 France Details
Research Site Villejuif 94805 France Details
Research Site Dublin 8 Ireland Details
Research Site Galway Ireland Details
Research Site Leicester LE1 5WW United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field